Form 4: Denali Therapeutics Director Vicki L Sato Reports Acquisition of Shares and Stock Options

Director Vicki L Sato reports acquisition of Denali Therapeutics shares and stock options.

Summary

• On May 31, 2024, Vicki L Sato, a director of Denali Therapeutics Inc. (DNLI), reported the acquisition of 5,967 shares of common stock.
• These shares were acquired through Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock.
• Sato also acquired 17,901 stock options with an exercise price of $18.56, exercisable starting May 31, 2024, and expiring on May 31, 2034.
• Following these transactions, Sato beneficially owns 122,336 shares of common stock, including 5,967 unvested RSUs, and 17,901 derivative securities.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard disclosure of stock transactions by a company director. The acquisitions could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.

Positives

• The acquisition of shares and stock options by a director may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in their company's stock. This allows investors to monitor insider activity, which can sometimes provide insights into a company's prospects.

Comparison to Industry Standards

• Comparing Vicki L Sato's transactions to those of other directors in similar biotechnology companies can provide context.
• For example, directors at companies like Biogen (BIIB) or Amgen (AMGN) also regularly report their transactions via Form 4 filings.
• Analyzing the size and frequency of these transactions relative to their holdings can offer insights into the director's sentiment and alignment with shareholder interests.

Stakeholder Impact

• The reported transactions provide transparency to shareholders regarding insider activity.
• The acquisition of shares and options by a director could be perceived positively by shareholders, potentially boosting investor confidence.

Key Dates